Rare diseases
Investigational molecules
Locations
Carretera De La Ronda Circunvalacion S/n, 11407 Jerez De La Frontera, Spain
Hospital Jerez de la Frontera in Jerez De La Frontera, Spain specialises in clinical trials of conditions such as Non-small cell lung cancer, Asthma, Plasma cell myeloma, Breast cancer, and other specialisations. This site conducts important research.
The Hospital Jerez de la Frontera is conducting research focused on advanced solid tumors within the broader field of neoplasms. The studies aim to assess new combination therapies for safety, tolerability, and antitumor activity.
With a team of 42 investigators, the site is advancing precision oncology by testing the investigational agent PF‑08634404 paired with partner compounds, seeking to improve outcomes for patients across Europe.
More sites in Jerez De La FronteraSpain
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
SpainStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
SpainStudy on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids
SpainStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
SpainStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
SpainStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
SpainRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
SpainEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
SpainPhase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments
SpainStudy of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors
SpainEIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer
SpainStudy of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
